- PROFESSOR Population Health Science and Policy
- DIRECTOR MOUNT SINAI INSTITUTE OF TECHNOLOGY
J.D., University of Pennsylvania Law School
B.A., Williams College
Geoffrey W. Smith is the founding Director of the Mount Sinai Institute of Technology at the Icahn School of Medicine at Mount Sinai (ISMMS). He is also a Professor in the Department of Population Health Science and Policy at ISMMS. Smith is a co-founder and General Partner of Ascent Biomedical Ventures, a venture capital firm focused on early-stage life sciences investments. He has been an active founder, manager, and investor in technology-based companies since 1995. He currently serves on the Board of Directors of Azevan Pharmaceuticals, Anterios, BackBeat Medical, Biomerix, Caliber Therapeutics, Coferon, TargAnox, and Vivasure Medical. Smith is also a Visiting Scholar at Rockefeller University where he founded and directs the University’s Science & Economics Program and is an adjunct faculty member at the RU Center for Clinical and Translational Science. Smith received a B.A. (with honors) from Williams College and a J.D. from the University of Pennsylvania Law School.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Smith during 2013 and/or 2014. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Mars, Inc.
Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:
- Anterios Inc.; Ascent Biomedical Ventures; Azevan Pharmaceuticals, Inc.; BackBeat Medical; Biomerix Corporation; Caliber Therapeutics, Inc.; Coferon, Inc.; FreeHold Surgical; TargAnox, Inc.; Vivasure Medical Ltd.
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- Cara Therapeutics
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Azevan Pharmaceuticals, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.